Does Folic Acid Supplementation Prevent or Promote Colorectal Cancer? Results from Model-Based Predictions
- 1 June 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (6) , 1360-1367
Abstract
Folate is essential for nucleotide synthesis, DNA replication, and methyl group supply. Low-folate status has been associated with increased risks of several cancer types, suggesting a chemopreventive role of folate. However, recent findings on giving folic acid to patients with a history of colorectal polyps raise concerns about the efficacy and safety of folate supplementation and the long-term health effects of folate fortification. Results suggest that undetected precursor lesions may progress under folic acid supplementation, consistent with the role of folate role in nucleotide synthesis and cell proliferation. To better understand the possible trade-offs between the protective effects due to decreased mutation rates and possibly concomitant detrimental effects due to increased cell proliferation of folic acid, we used a biologically based mathematical model of colorectal carcinogenesis. We predict changes in cancer risk based on timing of treatment start and the potential effect of folic acid on cell proliferation and mutation rates. Changes in colorectal cancer risk in response to folic acid supplementation are likely a complex function of treatment start, duration, and effect on cell proliferation and mutations rates. Predicted colorectal cancer incidence rates under supplementation are mostly higher than rates without folic acid supplementation unless supplementation is initiated early in life (before age 20 years). To the extent to which this model predicts reality, it indicates that the effect on cancer risk when starting folic acid supplementation late in life is small, yet mostly detrimental. Experimental studies are needed to provide direct evidence for this dual role of folate in colorectal cancer and to validate and improve the model predictions. (Cancer Epidemiol Biomarkers Prev 2008;17(6):OF1360–8)Keywords
This publication has 38 references indexed in Scilit:
- A Temporal Association between Folic Acid Fortification and an Increase in Colorectal Cancer Rates May Be Illuminating Important Biological Principles: A HypothesisCancer Epidemiology, Biomarkers & Prevention, 2007
- Folate and colorectal cancer: An evidence‐based critical reviewMolecular Nutrition & Food Research, 2007
- Folate Intake, MTHFR Polymorphisms, and Risk of Esophageal, Gastric, and Pancreatic Cancer: A Meta-analysisGastroenterology, 2006
- Folate Supplementation: Too Much of a Good Thing?Cancer Epidemiology, Biomarkers & Prevention, 2006
- A hierarchical non‐homogenous Poisson model for meta‐analysis of adenoma countsStatistics in Medicine, 2005
- Dietary Supplement Use by US Adults: Data from the National Health and Nutrition Examination Survey, 1999-2000American Journal of Epidemiology, 2004
- β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinBCell, 2002
- The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer CellsCell, 2002
- Modelling lung tumour risk in radon-exposed uranium miners using generalizations of the two-mutation model of Moolgavkar, Venzon and KnudsonInternational Journal of Radiation Biology, 2002
- A Nonidentifiability Aspect of the Two‐Stage Model of CarcinogenesisRisk Analysis, 1996